My 2 favourite low-P/E shares with big earnings potential

The cheap way to boost your wealth is to buy shares at low price-to-earnings multiples. But only a handful have real growth potential, says Tom Rodgers.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s easy enough to find undervalued shares for your Self-Invested Personal Pension or Stocks and Shares ISA. The more difficult part is picking those companies with real growth potential.

Even the best easy-access Cash ISA offers just 1.4% interest on your capital. That’s barely enough to cover the cost of inflation. Instead, I would choose shares that trade on a low price-to-earnings (P/E) multiple. That gives me the best chance to grow my wealth over time.

On a mission

It’s ironic that marketing and advertising specialist The Mission Group (LSE:TMG) doesn’t attract many headlines. Investors just don’t seem that smitten. But dig a little deeper and you might be surprised. A P/E ratio of just 10.5 looks very cheap, given that TMG has turned in decent profits on appreciating revenue for the past five years.

This AIM-listed firm hasn’t yet attracted the attention of many City analysts, whose forecasts shine a spotlight on underappreciated companies across the FTSE. A market cap of just £75m could be another reason this little gem has flown under the radar.

Like one of my best picks of last year, TP Group, the TMG share price has just slowly ticked upwards, adding 60% from its 60p price in February 2019 to a high of 96p in November that year. At last count the shares were trading at a 6% discount from their all time high.

A January trading update for the year ended 31 December 2019 showed the group with £5.8m profits on £159.9m revenue. Chair David Morgan confirmed that TMG should be debt-free by the end of 2020, adding: “More than ever, I am convinced that our positioning as a nimble and entrepreneurial group is right for our times.” I would agree.

Building growth

FTSE 250 housebuilder Vistry Group (LSE:VTY) has a very tidy looking balance sheet, certainly more so than larger competitors like Persimmon.

Last year, the company formerly known as Bovis Homes posted record profits with a net cash position of £362m, up from £126m. This was helped by a 3% hike in the number of completed new homes, a growing average selling price, and land acquisitions producing gross margins of 26% and 25% return on capital employed.

Recent appreciation in the share price means a cracking 6% yield has dropped to more like 4.3%. But we’re not only interested in VTY for the dividends. There are plenty of high-yield FTSE 100 companies that can do that particular job for your money.

The shares are now trading at a very reasonable P/E ratio of 13.8. When taking forecast earnings into account that drops to more like 10, which I say is very cheap for such a quality business.

Vistry said it produced a “significant step-up” in sales across 2019, with the average sales per outlet up from 0.5 the previous year to 0.58 this time round.

Full-year results for the 12 months ended 31 December 2019 are due out on 27 February and with chief executive Greg Fitzgerald highlighting a “strong” forward sales position the share price could go off like a rocket from here.

Tom Rodgers owns shares in The Mission Group. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »